Figure 7 Testing and evaluation of COVID-19 lead compounds in humans. The drug is administered to an appropriately chosen human population in different phases of clinical trials. The human subjects are regularly observed for any benefits or side effects of the drug administered. If the drug proves to be efficient with only minor side effects, then proceedings will start to obtain FDA approval. The drug can then be manufactured and commercialized.